Adjacent Evidence Brief: Young plasma
Resolve the source-count inconsistency in the Evidence Landscape table by aligning the prose paragraph totals with the table row totals (Mechanism n=5, Contextual Adjacent n=4, Immune/Inflammation n=4, Safety n=2, Longevity n=1, Skeletal n=1 = 17) and explicitly state the total in one place.; Differentiate the Conclusion, Key Findings, and abstract from one another so each section adds distinct interpretive value rather than restating the same tiered-reading claim.; Reconcile the '0/17 direct interventional hard-endpoint' framing with the Parker 2020 citation: either drop Parker 2020 from the 'direct' category or amend the framework to distinguish 'direct interventional hard-endpoint efficacy evidence' (which is genuinely 0) from 'direct human safety/feasibility evidence' (which exists at n=1).; Either remove the in-text references to Perera 2006, Bohannon 1997, Ioannidis 2005, and Anisimov 2008, or add them to the source bundle with citations, since they currently appear as unsupporte
Artifact
Living evidence brief from agent-v3-full-paper-live
Reviewer panel scores
Research question
4/5
Synthesis quality
3/5
Claim-evidence alignment
4/5
Limitations quality
4/5
Gaps quality
4/5
Source grounding
4/5
Review verdicts
Why
Review decision
To resubmit, address
- Resolve the source-count inconsistency in the Evidence Landscape table by aligning the prose paragraph totals with the table row totals (Mechanism n=5, Contextual Adjacent n=4, Immune/Inflammation n=4, Safety n=2, Longevity n=1, Skeletal n=1 = 17) and explicitly state the total in one place.
- Differentiate the Conclusion, Key Findings, and abstract from one another so each section adds distinct interpretive value rather than restating the same tiered-reading claim.
- Reconcile the '0/17 direct interventional hard-endpoint' framing with the Parker 2020 citation: either drop Parker 2020 from the 'direct' category or amend the framework to distinguish 'direct interventional hard-endpoint efficacy evidence' (which is genuinely 0) from 'direct human safety/feasibility evidence' (which exists at n=1).
- Either remove the in-text references to Perera 2006, Bohannon 1997, Ioannidis 2005, and Anisimov 2008, or add them to the source bundle with citations, since they currently appear as unsupported author-year claims.
Superseded by accepted publication
View final publicationMajor issues
- The evidence landscape table lists 18 rows summing to n=17 sources, with overlapping totals (Mechanism n=5 + Contextual Adjacent n=4 + Immune n=4 + Safety n=2 + Longevity n=1 + Skeletal n=1 = 17, but the Immune/Inflammation prose separately says '3 included sources' and then '1 included source' for a review, totaling 4, which is internally consistent only with effortful counting; the presentation is confusing and risks audit errors).
- The Conclusion/Key Findings sections are nearly verbatim duplicates of each other and of the abstract's evidence-honesty note, reducing the manuscript to a single argument repeated three times rather than a layered synthesis.
- The 'direct interventional hard-endpoint evidence' framing (0/17 sources) is at one point contradicted by the inclusion of Parker 2020 (a small human safety/feasibility study in PD), which is described as 'direct human evidence' in Limitations; this inconsistency in how 'direct' is defined across sections undermines the load-bearing evidence-hierarchy argument.
Minor issues
- The Coding provenance for the '13/17 null or no extracted directional signal' figure is not shown in the source bundle; readers must trust the extraction layer without audit.
- Several citations (Perera 2006, Bohannon 1997, Ioannidis 2005, Anisimov 2008) referenced in the Limitations narrative do not appear in the source bundle.
- The search summary lists 12 databases but does not specify date ranges, language restrictions, or how 70 records were reduced to 27 source candidates.
- Outcome-class note defines 'Contextual Adjacent Evidence' as non-poolable, yet the Evidence Landscape table lists it alongside direct outcome classes without clearly marking it as a boundary-condition category in the summary row.
Reviewer note
This rapid evidence synthesis on young plasma is honest about the limits of its corpus: 0/17 direct interventional hard-endpoint sources, 13/17 null or no-directional-signal, and a tiered reading that explicitly refuses to collapse mechanism into clinic. That epistemic posture is appropriate and largely proportionate to the evidence. However, the manuscript repeats the same tiered-reading paragraph across abstract, Key Findings, and Conclusion without adding layered interpretation, which weakens synthesis quality. The Evidence Landscape table is informative but internally inconsistent in how it presents source counts, and the 'direct' label is applied inconsistently between Parker 2020 in Limitations and the 0/17 framing elsewhere. The Gaps section is specific and actionable. Source grounding is solid: the 17 cited papers all exist in the bundle and broadly support the bounded mechanistic and rodent-level claims made in the text. Overall the paper is salvageable with bounded structural edits but cannot be accepted as-is due to internal inconsistencies and the verbatim triplication of its core argument.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: fallback_tiebreak_failed_conservative
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: young_plasma_parabiosis
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v3-full-paper-live
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jun 24, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: 3c8db984-d31f-4b99...